Paper37972575
Inhibition of transforming growth factor-β signals suppresses tumor formation by regulation of tumor microenvironment networks.
Tokizaki S and 12 others. Cancer Sci, 2024. Cited by 12 papers, by iCite.
Cite this record
ConductScience Library. Inhibition of transforming growth factor-β signals suppresses tumor formation by regulation of tumor microenvironment networks. Papers, record 37972575. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37972575
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Inhibition of transforming growth factor-β signals suppresses tumor formation by regulation of tumor microenvironment networks.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Protein Serine-Threonine Kinases | Major topic |
| Mouth Neoplasms | Major topic |
| Humans | |
| Mice | |
| Animals | |
| Transforming Growth Factor beta | |
| Heparin-binding EGF-like Growth Factor | |
| Endothelial Cells | |
| Tumor Microenvironment | |
| Receptors, Transforming Growth Factor beta | |
| Transforming Growth Factor beta1 | |
| Transforming Growth Factors |
Source PubMed
Grants10
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| JP21cm0106253 | Japan Agency for Medical Research and Development | PubMed | ||
| JP22ama221001 | Japan Agency for Medical Research and Development | PubMed | ||
| JP22ama221205 | Japan Agency for Medical Research and Development | PubMed | ||
| JPMJSP2120 | Japan Science and Technology Corporation SPRING | PubMed | ||
| JP20H00513 | Japan Society for the Promotion of Science | PubMed | ||
| JP20H03851 | Japan Society for the Promotion of Science | PubMed | ||
| JP20J11926 | Japan Society for the Promotion of Science | PubMed | ||
| JP20K10111 | Japan Society for the Promotion of Science | PubMed | ||
| JP21J01294 | Japan Society for the Promotion of Science | PubMed | ||
| JP23H05486 | Japan Society for the Promotion of Science | PubMed |
Source PubMed
References53
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36140527 | Epithelial-Mesenchymal Transition by Synergy between Transforming Growth Factor-β and Growth Factors in Cancer Progression. | Diagnostics (Basel) | 2022 | https://conductscience.org/library/papers/36140527 | PubMed |
| 2 | 19131956 | Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. | Nat Protoc | 2009 | https://conductscience.org/library/papers/19131956 | PubMed |
| 3 | 28718426 | Targeting TGF-β Signaling in Cancer. | Trends Cancer | 2017 | https://conductscience.org/library/papers/28718426 | PubMed |
| 4 | 34847944 | Endothelial-specific depletion of TGF-β signaling affects lymphatic function. | Inflamm Regen | 2021 | https://conductscience.org/library/papers/34847944 | PubMed |
| 5 | 19033363 | Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. | Nucleic Acids Res | 2009 | https://conductscience.org/library/papers/19033363 | PubMed |
| 6 | 12598651 | IL-1 is required for tumor invasiveness and angiogenesis. | Proc Natl Acad Sci U S A | 2003 | https://conductscience.org/library/papers/12598651 | PubMed |
| 7 | 30043220 | Intracellular and extracellular TGF-β signaling in cancer: some recent topics. | Front Med | 2018 | https://conductscience.org/library/papers/30043220 | PubMed |
| 8 | 23443317 | Molecular hierarchy of heparin-binding EGF-like growth factor-regulated angiogenesis in triple-negative breast cancer. | Mol Cancer Res | 2013 | https://conductscience.org/library/papers/23443317 | PubMed |
| 9 | 34884633 | The Role of EREG/EGFR Pathway in Tumor Progression. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34884633 | PubMed |
| 10 | 22837174 | Fc-fusion proteins: new developments and future perspectives. | EMBO Mol Med | 2012 | https://conductscience.org/library/papers/22837174 | PubMed |
| 11 | 35130955 | Emerging roles of inflammation-mediated endothelial-mesenchymal transition in health and disease. | Inflamm Regen | 2022 | https://conductscience.org/library/papers/35130955 | PubMed |
| 12 | 33756119 | Epithelial plasticity, epithelial-mesenchymal transition, and the TGF-β family. | Dev Cell | 2021 | https://conductscience.org/library/papers/33756119 | PubMed |
| 13 | 32914936 | Therapeutic Fc-fusion proteins: Current analytical strategies. | J Sep Sci | 2021 | https://conductscience.org/library/papers/32914936 | PubMed |
| 14 | 21376230 | Hallmarks of cancer: the next generation. | Cell | 2011 | https://conductscience.org/library/papers/21376230 | PubMed |
| 15 | 22187661 | Roles of TGF-β signals in endothelial-mesenchymal transition during cardiac fibrosis. | Int J Inflam | 2011 | https://conductscience.org/library/papers/22187661 | PubMed |
| 16 | 34344357 | IL-1β augments TGF-β inducing epithelial-mesenchymal transition of epithelial cells and associates with poor pulmonary function improvement in neutrophilic asthmatics. | Respir Res | 2021 | https://conductscience.org/library/papers/34344357 | PubMed |
| 17 | 24680771 | Heparin-binding epidermal growth factor-like growth factor (HB-EGF) and proteolytic processing by a disintegrin and metalloproteinases (ADAM): a regulator of several pathways. | Semin Cell Dev Biol | 2014 | https://conductscience.org/library/papers/24680771 | PubMed |
| 18 | 34296292 | Progression of melanoma is suppressed by targeting all transforming growth factor‑β isoforms with an Fc chimeric receptor. | Oncol Rep | 2021 | https://conductscience.org/library/papers/34296292 | PubMed |
| 19 | 30142332 | Heparin-Binding Epidermal Growth Factor-Like Growth Factor as a Critical Mediator of Tissue Repair and Regeneration. | Am J Pathol | 2018 | https://conductscience.org/library/papers/30142332 | PubMed |
| 20 | 33659878 | Interplay between tumor microenvironment and partial EMT as the driver of tumor progression. | iScience | 2021 | https://conductscience.org/library/papers/33659878 | PubMed |
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42639393 | Molecular mechanisms of therapeutic resistance in areca nut-associated oral squamous cell carcinoma: the interplay of chronic inflammation and epithelial-mesenchymal transition. | Front Oncol | 2026 | https://conductscience.org/library/papers/42639393 | PubMed |
| 41615651 | TGF-β in tumor development and progression: mechanisms and therapeutics. | Mol Biomed | 2026 | https://conductscience.org/library/papers/41615651 | PubMed |
| 41007646 | Editorial for the Special Issue "Anticancer Activity and Metabolic Pathways of Natural Products 2.0". | Biomedicines | 2025 | https://conductscience.org/library/papers/41007646 | PubMed |
| 39851099 | Angelicin Inhibits NSCLC Tumor Growth via the Inhibition of Cancer-Associated Fibroblasts. | Comb Chem High Throughput Screen | 2026 | https://conductscience.org/library/papers/39851099 | PubMed |
| 39840050 | Role of tertiary lymphoid structures and B cells in clinical immunotherapy of gastric cancer. | Front Immunol | 2024 | https://conductscience.org/library/papers/39840050 | PubMed |
| 38927551 | Exploring Novel Frontiers in Cancer Therapy. | Biomedicines | 2024 | https://conductscience.org/library/papers/38927551 | PubMed |
| 38398101 | Role of Epiregulin in Lung Tumorigenesis and Therapeutic Resistance. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/38398101 | PubMed |
| 38111334 | CD40 is expressed in the subsets of endothelial cells undergoing partial endothelial-mesenchymal transition in tumor microenvironment. | Cancer Sci | 2024 | https://conductscience.org/library/papers/38111334 | PubMed |
| 37972575 | Inhibition of transforming growth factor-β signals suppresses tumor formation by regulation of tumor microenvironment networks. | Cancer Sci | 2024 | https://conductscience.org/library/papers/37972575 | PubMed |
Genes24
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37972575
GET https://conductscience.org/api/papers/v1/37972575/references?page=2